[Elsevier] Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial

Busq Post time Yesterday 18:29 | Show all posts |Read mode
This post will be closed automatically in 2026-07-01 18:28
Reward10points


Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list